Screener
ADMA Biologics ADMA Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's invested capital?
- ADMA Biologics (ADMA) reported invested capital of $476.08M in Q2 2026.
- How has ADMA Biologics's invested capital changed year-over-year?
- ADMA Biologics's invested capital increased by 49.5% year-over-year, from $318.47M to $476.08M.
- What is the long-term trend for ADMA Biologics's invested capital?
- Over 5 years (2020 to 2025), ADMA Biologics's invested capital has grown at a 29.3% compound annual growth rate (CAGR), from $130M to $469.53M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about ADMA Biologics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude